Global Insulin Delivery Devices Market Insights and Forecast to 2026

Global Insulin Delivery Devices Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Insulin Delivery Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Delivery Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Insulin Delivery Devices Market Size Growth Rate by Type
1.4.2 Insulin Pens
1.4.3 Insulin Pumps
1.4.4 Insulin Syringes
1.4.5 Others
1.5 Market by Application
1.5.1 Global Insulin Delivery Devices Market Size Growth Rate by Application
1.5.2 Patients/Homecare
1.5.3 Hospitals & Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Insulin Delivery Devices Market Size, Estimates and Forecasts
2.1.1 Global Insulin Delivery Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Insulin Delivery Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Insulin Delivery Devices Production Estimates and Forecasts 2015-2026
2.2 Global Insulin Delivery Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Insulin Delivery Devices Manufacturers Geographical Distribution
2.4 Key Trends for Insulin Delivery Devices Markets & Products
2.5 Primary Interviews with Key Insulin Delivery Devices Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Insulin Delivery Devices Manufacturers by Production Capacity
3.1.1 Global Top Insulin Delivery Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Insulin Delivery Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Insulin Delivery Devices Manufacturers Market Share by Production
3.2 Global Top Insulin Delivery Devices Manufacturers by Revenue
3.2.1 Global Top Insulin Delivery Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Insulin Delivery Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Delivery Devices Revenue in 2019
3.3 Global Insulin Delivery Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Insulin Delivery Devices Production by Regions
4.1 Global Insulin Delivery Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Insulin Delivery Devices Regions by Production (2015-2020)
4.1.2 Global Top Insulin Delivery Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Insulin Delivery Devices Production (2015-2020)
4.2.2 North America Insulin Delivery Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Insulin Delivery Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Insulin Delivery Devices Production (2015-2020)
4.3.2 Europe Insulin Delivery Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Insulin Delivery Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Insulin Delivery Devices Production (2015-2020)
4.4.2 China Insulin Delivery Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Insulin Delivery Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Insulin Delivery Devices Production (2015-2020)
4.5.2 Japan Insulin Delivery Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Insulin Delivery Devices Import & Export (2015-2020)
5 Insulin Delivery Devices Consumption by Region
5.1 Global Top Insulin Delivery Devices Regions by Consumption
5.1.1 Global Top Insulin Delivery Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Insulin Delivery Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Insulin Delivery Devices Consumption by Application
5.2.2 North America Insulin Delivery Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Insulin Delivery Devices Consumption by Application
5.3.2 Europe Insulin Delivery Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Insulin Delivery Devices Consumption by Application
5.4.2 Asia Pacific Insulin Delivery Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Insulin Delivery Devices Consumption by Application
5.5.2 Central & South America Insulin Delivery Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Insulin Delivery Devices Consumption by Application
5.6.2 Middle East and Africa Insulin Delivery Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Insulin Delivery Devices Market Size by Type (2015-2020)
6.1.1 Global Insulin Delivery Devices Production by Type (2015-2020)
6.1.2 Global Insulin Delivery Devices Revenue by Type (2015-2020)
6.1.3 Insulin Delivery Devices Price by Type (2015-2020)
6.2 Global Insulin Delivery Devices Market Forecast by Type (2021-2026)
6.2.1 Global Insulin Delivery Devices Production Forecast by Type (2021-2026)
6.2.2 Global Insulin Delivery Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Insulin Delivery Devices Price Forecast by Type (2021-2026)
6.3 Global Insulin Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Insulin Delivery Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Insulin Delivery Devices Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Novo Nordisk
8.1.1 Novo Nordisk Corporation Information
8.1.2 Novo Nordisk Overview
8.1.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Novo Nordisk Product Description
8.1.5 Novo Nordisk Related Developments
8.2 Sanofi
8.2.1 Sanofi Corporation Information
8.2.2 Sanofi Overview
8.2.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Sanofi Product Description
8.2.5 Sanofi Related Developments
8.3 BD
8.3.1 BD Corporation Information
8.3.2 BD Overview
8.3.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 BD Product Description
8.3.5 BD Related Developments
8.4 Eli Lilly
8.4.1 Eli Lilly Corporation Information
8.4.2 Eli Lilly Overview
8.4.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Eli Lilly Product Description
8.4.5 Eli Lilly Related Developments
8.5 Medtronic
8.5.1 Medtronic Corporation Information
8.5.2 Medtronic Overview
8.5.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Medtronic Product Description
8.5.5 Medtronic Related Developments
8.6 Animas
8.6.1 Animas Corporation Information
8.6.2 Animas Overview
8.6.3 Animas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Animas Product Description
8.6.5 Animas Related Developments
8.7 Beta Bionics
8.7.1 Beta Bionics Corporation Information
8.7.2 Beta Bionics Overview
8.7.3 Beta Bionics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Beta Bionics Product Description
8.7.5 Beta Bionics Related Developments
8.8 Cellnovo
8.8.1 Cellnovo Corporation Information
8.8.2 Cellnovo Overview
8.8.3 Cellnovo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Cellnovo Product Description
8.8.5 Cellnovo Related Developments
8.9 Copernicus
8.9.1 Copernicus Corporation Information
8.9.2 Copernicus Overview
8.9.3 Copernicus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Copernicus Product Description
8.9.5 Copernicus Related Developments
8.10 Dance Biopharm
8.10.1 Dance Biopharm Corporation Information
8.10.2 Dance Biopharm Overview
8.10.3 Dance Biopharm Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Dance Biopharm Product Description
8.10.5 Dance Biopharm Related Developments
8.11 Debiotech
8.11.1 Debiotech Corporation Information
8.11.2 Debiotech Overview
8.11.3 Debiotech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Debiotech Product Description
8.11.5 Debiotech Related Developments
8.12 Insulet
8.12.1 Insulet Corporation Information
8.12.2 Insulet Overview
8.12.3 Insulet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Insulet Product Description
8.12.5 Insulet Related Developments
8.13 MannKind
8.13.1 MannKind Corporation Information
8.13.2 MannKind Overview
8.13.3 MannKind Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 MannKind Product Description
8.13.5 MannKind Related Developments
8.14 Owen Mumford
8.14.1 Owen Mumford Corporation Information
8.14.2 Owen Mumford Overview
8.14.3 Owen Mumford Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Owen Mumford Product Description
8.14.5 Owen Mumford Related Developments
8.15 Roche
8.15.1 Roche Corporation Information
8.15.2 Roche Overview
8.15.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Roche Product Description
8.15.5 Roche Related Developments
8.16 SOOIL
8.16.1 SOOIL Corporation Information
8.16.2 SOOIL Overview
8.16.3 SOOIL Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 SOOIL Product Description
8.16.5 SOOIL Related Developments
8.17 Tandem Diabetes Care
8.17.1 Tandem Diabetes Care Corporation Information
8.17.2 Tandem Diabetes Care Overview
8.17.3 Tandem Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Tandem Diabetes Care Product Description
8.17.5 Tandem Diabetes Care Related Developments
8.18 Valeritas
8.18.1 Valeritas Corporation Information
8.18.2 Valeritas Overview
8.18.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 Valeritas Product Description
8.18.5 Valeritas Related Developments
8.19 West Pharma
8.19.1 West Pharma Corporation Information
8.19.2 West Pharma Overview
8.19.3 West Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.19.4 West Pharma Product Description
8.19.5 West Pharma Related Developments
8.20 Ypsomed
8.20.1 Ypsomed Corporation Information
8.20.2 Ypsomed Overview
8.20.3 Ypsomed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.20.4 Ypsomed Product Description
8.20.5 Ypsomed Related Developments
9 Insulin Delivery Devices Production Forecast by Regions
9.1 Global Top Insulin Delivery Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Insulin Delivery Devices Regions Forecast by Production (2021-2026)
9.3 Key Insulin Delivery Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Insulin Delivery Devices Consumption Forecast by Region
10.1 Global Insulin Delivery Devices Consumption Forecast by Region (2021-2026)
10.2 North America Insulin Delivery Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Insulin Delivery Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Insulin Delivery Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Insulin Delivery Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Insulin Delivery Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Delivery Devices Sales Channels
11.2.2 Insulin Delivery Devices Distributors
11.3 Insulin Delivery Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Insulin Delivery Devices Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 Insulin Delivery Devices Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Insulin Delivery Devices Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Insulin Delivery Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Insulin Delivery Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Delivery Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Insulin Pens
Table 5. Major Manufacturers of Insulin Pumps
Table 6. Major Manufacturers of Insulin Syringes
Table 7. Major Manufacturers of Others
Table 8. Global Insulin Delivery Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Insulin Delivery Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 10. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 11. Global Insulin Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Delivery Devices as of 2019)
Table 12. Insulin Delivery Devices Manufacturing Base Distribution and Headquarters
Table 13. Manufacturers Insulin Delivery Devices Product Offered
Table 14. Date of Manufacturers Enter into Insulin Delivery Devices Market
Table 15. Key Trends for Insulin Delivery Devices Markets & Products
Table 16. Main Points Interviewed from Key Insulin Delivery Devices Players
Table 17. Global Insulin Delivery Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 18. Global Insulin Delivery Devices Production Share by Manufacturers (2015-2020)
Table 19. Insulin Delivery Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Insulin Delivery Devices Revenue Share by Manufacturers (2015-2020)
Table 21. Insulin Delivery Devices Price by Manufacturers 2015-2020 (USD/Unit)
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insulin Delivery Devices Production by Regions (2015-2020) (K Units)
Table 24. Global Insulin Delivery Devices Production Market Share by Regions (2015-2020)
Table 25. Global Insulin Delivery Devices Revenue by Regions (2015-2020) (US$ Million)
Table 26. Global Insulin Delivery Devices Revenue Market Share by Regions (2015-2020)
Table 27. Key Insulin Delivery Devices Players in North America
Table 28. Import & Export of Insulin Delivery Devices in North America (K Units)
Table 29. Key Insulin Delivery Devices Players in Europe
Table 30. Import & Export of Insulin Delivery Devices in Europe (K Units)
Table 31. Key Insulin Delivery Devices Players in China
Table 32. Import & Export of Insulin Delivery Devices in China (K Units)
Table 33. Key Insulin Delivery Devices Players in Japan
Table 34. Import & Export of Insulin Delivery Devices in Japan (K Units)
Table 35. Global Insulin Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 36. Global Insulin Delivery Devices Consumption Market Share by Regions (2015-2020)
Table 37. North America Insulin Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 38. North America Insulin Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 39. Europe Insulin Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 40. Europe Insulin Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 41. Asia Pacific Insulin Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 42. Asia Pacific Insulin Delivery Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 43. Asia Pacific Insulin Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 44. Latin America Insulin Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 45. Latin America Insulin Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 46. Middle East and Africa Insulin Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 47. Middle East and Africa Insulin Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 48. Global Insulin Delivery Devices Production by Type (2015-2020) (K Units)
Table 49. Global Insulin Delivery Devices Production Share by Type (2015-2020)
Table 50. Global Insulin Delivery Devices Revenue by Type (2015-2020) (Million US$)
Table 51. Global Insulin Delivery Devices Revenue Share by Type (2015-2020)
Table 52. Insulin Delivery Devices Price by Type 2015-2020 (USD/Unit)
Table 53. Global Insulin Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 54. Global Insulin Delivery Devices Consumption Share by Application (2015-2020)
Table 55. Novo Nordisk Corporation Information
Table 56. Novo Nordisk Description and Major Businesses
Table 57. Novo Nordisk Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 58. Novo Nordisk Product
Table 59. Novo Nordisk Recent Development
Table 60. Sanofi Corporation Information
Table 61. Sanofi Description and Major Businesses
Table 62. Sanofi Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Sanofi Product
Table 64. Sanofi Recent Development
Table 65. BD Corporation Information
Table 66. BD Description and Major Businesses
Table 67. BD Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. BD Product
Table 69. BD Recent Development
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Major Businesses
Table 72. Eli Lilly Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Eli Lilly Product
Table 74. Eli Lilly Recent Development
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Major Businesses
Table 77. Medtronic Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Medtronic Product
Table 79. Medtronic Recent Development
Table 80. Animas Corporation Information
Table 81. Animas Description and Major Businesses
Table 82. Animas Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Animas Product
Table 84. Animas Recent Development
Table 85. Beta Bionics Corporation Information
Table 86. Beta Bionics Description and Major Businesses
Table 87. Beta Bionics Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Beta Bionics Product
Table 89. Beta Bionics Recent Development
Table 90. Cellnovo Corporation Information
Table 91. Cellnovo Description and Major Businesses
Table 92. Cellnovo Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Cellnovo Product
Table 94. Cellnovo Recent Development
Table 95. Copernicus Corporation Information
Table 96. Copernicus Description and Major Businesses
Table 97. Copernicus Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Copernicus Product
Table 99. Copernicus Recent Development
Table 100. Dance Biopharm Corporation Information
Table 101. Dance Biopharm Description and Major Businesses
Table 102. Dance Biopharm Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Dance Biopharm Product
Table 104. Dance Biopharm Recent Development
Table 105. Debiotech Corporation Information
Table 106. Debiotech Description and Major Businesses
Table 107. Debiotech Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Debiotech Product
Table 109. Debiotech Recent Development
Table 110. Insulet Corporation Information
Table 111. Insulet Description and Major Businesses
Table 112. Insulet Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Insulet Product
Table 114. Insulet Recent Development
Table 115. MannKind Corporation Information
Table 116. MannKind Description and Major Businesses
Table 117. MannKind Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. MannKind Product
Table 119. MannKind Recent Development
Table 120. Owen Mumford Corporation Information
Table 121. Owen Mumford Description and Major Businesses
Table 122. Owen Mumford Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Owen Mumford Product
Table 124. Owen Mumford Recent Development
Table 125. Roche Corporation Information
Table 126. Roche Description and Major Businesses
Table 127. Roche Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Roche Product
Table 129. Roche Recent Development
Table 130. SOOIL Corporation Information
Table 131. SOOIL Description and Major Businesses
Table 132. SOOIL Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. SOOIL Product
Table 134. SOOIL Recent Development
Table 135. Tandem Diabetes Care Corporation Information
Table 136. Tandem Diabetes Care Description and Major Businesses
Table 137. Tandem Diabetes Care Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Tandem Diabetes Care Product
Table 139. Tandem Diabetes Care Recent Development
Table 140. Valeritas Corporation Information
Table 141. Valeritas Description and Major Businesses
Table 142. Valeritas Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Valeritas Product
Table 144. Valeritas Recent Development
Table 145. West Pharma Corporation Information
Table 146. West Pharma Description and Major Businesses
Table 147. West Pharma Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. West Pharma Product
Table 149. West Pharma Recent Development
Table 150. Ypsomed Corporation Information
Table 151. Ypsomed Description and Major Businesses
Table 152. Ypsomed Insulin Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Ypsomed Product
Table 154. Ypsomed Recent Development
Table 155. Global Insulin Delivery Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 156. Global Insulin Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Table 157. Global Insulin Delivery Devices Production Forecast by Type (2021-2026) (K Units)
Table 158. Global Insulin Delivery Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 159. North America Insulin Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 160. Europe Insulin Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 161. Asia Pacific Insulin Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 162. Latin America Insulin Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 163. Middle East and Africa Insulin Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 164. Insulin Delivery Devices Distributors List
Table 165. Insulin Delivery Devices Customers List
Table 166. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 167. Key Challenges
Table 168. Market Risks
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Delivery Devices Product Picture
Figure 2. Global Insulin Delivery Devices Production Market Share by Type in 2020 & 2026
Figure 3. Insulin Pens Product Picture
Figure 4. Insulin Pumps Product Picture
Figure 5. Insulin Syringes Product Picture
Figure 6. Others Product Picture
Figure 7. Global Insulin Delivery Devices Consumption Market Share by Application in 2020 & 2026
Figure 8. Patients/Homecare
Figure 9. Hospitals & Clinics
Figure 10. Insulin Delivery Devices Report Years Considered
Figure 11. Global Insulin Delivery Devices Revenue 2015-2026 (Million US$)
Figure 12. Global Insulin Delivery Devices Production Capacity 2015-2026 (K Units)
Figure 13. Global Insulin Delivery Devices Production 2015-2026 (K Units)
Figure 14. Global Insulin Delivery Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Insulin Delivery Devices Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Insulin Delivery Devices Revenue in 2019
Figure 18. Global Insulin Delivery Devices Production Market Share by Region (2015-2020)
Figure 19. Insulin Delivery Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Insulin Delivery Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Insulin Delivery Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Insulin Delivery Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Insulin Delivery Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Insulin Delivery Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Insulin Delivery Devices Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Insulin Delivery Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Insulin Delivery Devices Consumption Market Share by Regions 2015-2020
Figure 28. North America Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Insulin Delivery Devices Consumption Market Share by Application in 2019
Figure 30. North America Insulin Delivery Devices Consumption Market Share by Countries in 2019
Figure 31. U.S. Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Insulin Delivery Devices Consumption Market Share by Application in 2019
Figure 35. Europe Insulin Delivery Devices Consumption Market Share by Countries in 2019
Figure 36. Germany Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Insulin Delivery Devices Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Insulin Delivery Devices Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Insulin Delivery Devices Consumption Market Share by Regions in 2019
Figure 44. China Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Insulin Delivery Devices Consumption and Growth Rate (K Units)
Figure 56. Latin America Insulin Delivery Devices Consumption Market Share by Application in 2019
Figure 57. Latin America Insulin Delivery Devices Consumption Market Share by Countries in 2019
Figure 58. Mexico Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Insulin Delivery Devices Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Insulin Delivery Devices Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Insulin Delivery Devices Consumption Market Share by Countries in 2019
Figure 64. Turkey Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Insulin Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Insulin Delivery Devices Production Market Share by Type (2015-2020)
Figure 68. Global Insulin Delivery Devices Production Market Share by Type in 2019
Figure 69. Global Insulin Delivery Devices Revenue Market Share by Type (2015-2020)
Figure 70. Global Insulin Delivery Devices Revenue Market Share by Type in 2019
Figure 71. Global Insulin Delivery Devices Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Insulin Delivery Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Insulin Delivery Devices Market Share by Price Range (2015-2020)
Figure 74. Global Insulin Delivery Devices Consumption Market Share by Application (2015-2020)
Figure 75. Global Insulin Delivery Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Insulin Delivery Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 77. Global Insulin Delivery Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 78. Global Insulin Delivery Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 79. Global Insulin Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Figure 80. North America Insulin Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 81. North America Insulin Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 82. Europe Insulin Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 83. Europe Insulin Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 84. China Insulin Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 85. China Insulin Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 86. Japan Insulin Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 87. Japan Insulin Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 88. Global Insulin Delivery Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 89. Insulin Delivery Devices Value Chain
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Porter's Five Forces Analysis
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Non-Invasive Glucose Meter Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79

This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......

Global Glucose Meter Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106

Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......

Global Blood Glucose Testing Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101

Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......

Global Glucose Biosensors Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139

According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......

Global Artificial Pancreas Devices Systems Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100

According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......

Global Blood Glucose Testing Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130

According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......

Global Lancing Devices Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......

Global Non-Invasive Glucose Meter Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......

Global Glucose Meter Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs